The Promise of PROMIS in Pelvic Organ Prolapse.


Journal

Female pelvic medicine & reconstructive surgery
ISSN: 2154-4212
Titre abrégé: Female Pelvic Med Reconstr Surg
Pays: United States
ID NLM: 101528690

Informations de publication

Date de publication:
Historique:
pubmed: 21 12 2018
medline: 9 4 2020
entrez: 21 12 2018
Statut: ppublish

Résumé

The aims of the study were to determine the relationship between pelvic organ prolapse (POP) and health-related quality of life dimensions and to evaluate the utility of the PROMIS Profile in women undergoing surgical treatment for POP. We performed a planned ancillary analysis of 103 women recruited between January 2014 and December 2015 to the Restricted Convalescence Outcomes following Urogynecologic Procedures study. All participants underwent surgery for POP and completed the Pelvic Floor Distress Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), Patient Global Impression of Severity Scale, and the 57-item Patient Reported Outcomes Measurement Information System (PROMIS-57) questionnaire, preoperatively and at 3 months postoperatively. Data were analyzed using Pearson and Spearman correlations. Preoperative PFDI-20 and PFIQ-7 scores were significantly correlated with all PROMIS domains including physical function, anxiety, depression, fatigue, sleep disturbance, satisfaction with participation in social roles, pain interference, and higher pain intensity. Worse self-reported condition assessments on the Patient Global Impression of Severity were significantly correlated with worse physical function, more pain interference, and higher pain intensity on the PROMIS Profile at baseline. Postoperatively, PFDI-20, PFIQ-7, and all PROMIS Profile domain scores improved significantly (P ≤ 0.05). Correlations between PDFI-20, PFIQ-7, and PROMIS domains persisted at 3 months. In a cohort of women undergoing surgery for POP, pelvic floor symptom severity is associated with health-related quality of life domains measured by the PROMIS-57.

Identifiants

pubmed: 30570502
doi: 10.1097/SPV.0000000000000685
doi:

Banques de données

ClinicalTrials.gov
['NCT02138487']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

426-429

Auteurs

Katarzyna Bochenska (K)

From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology.

Evelyn Hall (E)

From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology.

James W Griffith (JW)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL.

Kimberly Kenton (K)

From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology.

Alexandria Alverdy (A)

From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology.

Christina Lewicky-Gaupp (C)

From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology.

Margaret Mueller (M)

From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH